InMode to Present at Upcoming Virtual Conferences in August
InMode Ltd. (Nasdaq: INMD) has announced participation in several virtual conferences in August 2020. Key executives, including CEO Moshe Mizrahy and CFO Yair Malca, will present at the UBS Genomics 2.0 and Medtech Innovations Virtual Summit and the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020. They will also host investor meetings during the 5th Annual Needham Virtual Med Tech 1x1 Conference on August 17, 2020. Live webcasts of presentations will be available at InMode Investors.
- None.
- None.
YOKNEAM, Israel, Aug. 3, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, co-founder and Chief Technology Officer, Yair Malca, Chief Financial Officer, Dr. Spero Theodorou, Chief Medical Officer, and Shakil Lakhani, President of North America will participate at the following virtual conferences:
UBS Genomics 2.0 and Medtech Innovations Virtual Summit
Management will participate in a virtual fireside chat on Thursday, August 13, 2020 at 9:00 a.m. EDT and will be available for one-on-one meetings throughout the day.
Canaccord Genuity 40th Annual Growth Conference
Management will present virtually on Thursday, August 13, 2020 at 11:30 a.m. EDT and will be available for one-on-one meetings on Wednesday, August 12, 2020.
5th Annual Needham Virtual Med Tech 1x1 Conference
Management will host virtual one-on-one investor meetings on Monday, August 17, 2020.
To schedule a meeting please contact your salesperson or Miri Segal at msegal@ms-ir.com.
A live webcast of the presentations will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentations.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
View original content:http://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-virtual-conferences-in-august-301104367.html
SOURCE InMode Ltd.
FAQ
When is InMode participating in the UBS Genomics 2.0 Summit?
What time is InMode's presentation at the Canaccord Genuity Conference?
When will InMode host one-on-one meetings during the Needham Conference?
Where can I watch the live webcast of InMode's presentations?
Who are the key executives presenting for InMode?
